Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/24 18:13 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | COO,CFO | 5 | S.d | -1,290 | 15.40 | 0 | -84 | 211 | D | |||||||||||||||
2/20/24 16:58 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Qatanani Mo | MA | O | CHIEF SC | 4 | S.d | -532 | 17.10 | 0 | -31 | 147 | D | |||||||||||||||
2/20/24 16:52 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Parlavecchio Caryn | MA | O | CHRO | 3 | S | -114 | 14.29 | 0 | -8 | 158 | D | |||||||||||||||
2/20/24 16:48 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Ho Junlin | MA | O | GC | 2 | S | -122 | 15.84 | 0 | -8 | 209 | D | |||||||||||||||
2/20/24 16:46 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Backstrom Jay T. | MA | DO | CEO | 1 | S | -183 | 15.74 | 0 | -12 | 353 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |